Stability of leukemia-associated immunophenotypes in precursor B-lymphoblastic leukemia/lymphoma: a single institution experience.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  American Journal of Clinical Pathology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1309/7R6MU7R9YWJBY5V4PMID 17145625
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection

  2005cited by this paper
• Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: Implications for residual disease detection: A report from the children's oncology group

  2005cited by this paper
• Concurrent detection of minimal residual disease (MRD) in childhood acute lymphoblastic leukaemia by flow cytometry and real‐time PCR

  2005cited by this paper
• Comparative analysis of flow cytometry and polymerase chain reaction for the detection of minimal residual disease in childhood acute lymphoblastic leukemia

  2004cited by this paper
• Immunophenotypic Analysis of Hematogones (B-Lymphocyte Precursors) and Neoplastic Lymphoblasts by 4-Color Flow Cytometry

  2004cited by this paper
• Minimal residual disease monitoring by flow cytometry.

  2003cited by this paper
• Flow cytometric follow-up of minimal residual disease in bone marrow gives prognostic information in children with acute lymphoblastic leukemia

  2003cited by this paper
• Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia.

  2002cited by this paper
• Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia.

  2002cited by this paper
• Flow cytometry and allele-specific oligonucleotide PCR are equally effective in detection of minimal residual disease in ALL

  2001cited by this paper
• Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry.

  2001cited by this paper
• Immunophenotypic and cytogenetic changes in acute leukaemia at relapse.

  2001cited by this paper
• Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia.

  2000cited by this paper
• Shift of aberrant antigen expression at relapse or at treatment failure in acute leukemia.

  2000cited by this paper
• A limited antibody panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four color flow cytometry: implications for residual disease detection

  1999cited by this paper
• Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: cancer and leukemia Group B study 8364.

  1999cited by this paper
• Immunophenotype of adult and childhood acute lymphoblastic leukemia: changes at first relapse and clinico-prognostic implications

  1997cited by this paper
• Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysis.

  1994cited by this paper
• Flow cytometric detection of rare normal human marrow cells with immunophenotypes characteristic of acute lymphoblastic leukemia cells.

  1992cited by this paper
• Morphologic, immunologic and cytogenetic studies in children with acute lymphoblastic leukemia at diagnosis and relapse: a Pediatric Oncology Group study.

  1992cited by this paper
• Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse.

  1991cited by this paper
• Second neoplasms after acute lymphoblastic leukemia in childhood.

  1991cited by this paper
• Significance of aberrant immunophenotypes in childhood acute lymphoid leukemia

  1991cited by this paper
• Molecular heterogeneity in acute leukemia lineage switch.

  1989cited by this paper
• Asynchronous antigen expression in B lineage acute lymphoblastic leukemia.

  1988cited by this paper
• Analyses of phenotype and genotype in acute lymphoblastic leukemias at first presentation and in relapse.

  1987cited by this paper

• Comparison of Measurable Residual Disease in Pediatric B-Lymphoblastic Leukemia Using Multiparametric Flow Cytometry and Next-Generation Sequencing

  2024cites this paper
• Association of B-Lineage Lymphoblastic Leukaemia Gene Polymorphisms with Poor Prognostic Features

  2024cites this paper
• LILRB1.

  2021cites this paper
• Minimal Residual Disease Detection in Pediatric Acute Lymphoblastic Leukemia

  2020cites this paper
• ETV6-RUNX1阳性儿童急性淋巴细胞白血病基因表达谱聚类的临床特征

  2020cites this paper
• Precursor B-lineage acute lymphoblastic leukemia patients with aberrant natural killer cell and T cell – lineage antigen expression: experience from a tertiary cancer care center

  2020cites this paper
• Minimal/Measurable Residual Disease Detection in Acute Leukemias by Multiparameter Flow Cytometry

  2018cites this paper
• Differential expression of CD73, CD86 and CD304 in normal vs. leukemic B-cell precursors and their utility as stable minimal residual disease markers in childhood B-cell precursor acute lymphoblastic leukemia.

  2018cites this paper
• Flow cytometric minimal residual disease assessment of peripheral blood in acute lymphoblastic leukaemia patients has potential for early detection of relapsed extramedullary disease

  2018cites this paper
• Neuropilin-1/CD304 Expression by Flow Cytometry in Pediatric Precursor B-Acute Lymphoblastic Leukemia: A Minimal Residual Disease and Potential Prognostic Marker

  2017cites this paper
• Flow Cytometry of B-Cell Neoplasms.

  2017cites this paper
• Initial Diagnostic Workup of Acute Leukemia: Guideline From the College of American Pathologists and the American Society of Hematology.

  2017cites this paper
• B Lymphoblastic Leukemia Minimal Residual Disease Assessment by Flow Cytometric Analysis.

  2017cites this paper
• Molecular Pathology in Cancer Research

  2016cites this paper
• Nanomedicine approaches in acute lymphoblastic leukemia.

  2016cites this paper
• Flow Cytometric Evaluation of Double/Triple Hit Lymphoma

  2016cites this paper
• Clinical Flow Cytometry for Hematopoietic Neoplasms

  2016cites this paper
• A 10 Years Survey of Acute Lymphoblastic Leukemia in Northwest of Iran: Immunophenotyping Assessment and its Relation to Induction Therapy

  2015influential citation
• Thymic Immunophenotype, and Expression of CD4 and Myeloid Antigens isAssociated with Outcome in Adult Patients with TâÂÂCell Acute LymphoblasticLeukemia

  2015cites this paper
• B-acute lymphoblastic leukemia/lymphoblastic lymphoma.

  2015cites this paper
• Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A french multicenter study

  2014cites this paper
• Detection of Minimal Residual Disease in B Lymphoblastic Leukemia by High-Throughput Sequencing of IGH

  2014cites this paper
• Apparent CD19 expression by natural killer cells: A potential confounder for minimal residual disease detection by flow cytometry in B lymphoblastic leukemia

  2014cites this paper
• Minimal residual disease testing in acute leukemia

  2013cites this paper
• ZAP‐70 and Bcl‐2 expression in B lymphoblastic leukemia cells and hematogones

  2012influential citation
• A dissection of the CD45/side scatter "blast gate".

  2012cites this paper
• CD304 is preferentially expressed on a subset of B‐lineage acute lymphoblastic leukemia and represents a novel marker for minimal residual disease detection by flow cytometry

  2012cites this paper
• Multiparameter flow cytometry in the diagnosis and management of acute leukemia.

  2011cites this paper
• Neoplastic Pathology of the Blood and Bone Marrow in Pediatric Pathology

  2011cites this paper
• The immunophenotypic stability of plasma cell myeloma by flow cytometry

  2011cites this paper
• Flow Cytometry Evaluation of Minimal Residual Disease in Acute Lymphoblastic Leukaemia Type B

  2010cites this paper
• Immunophenotypic stability of T‐cell large granular lymphocytic leukaemia by flow cytometry

  2010cites this paper
• Lymphoblastic Leukemia and Lymphoma

  2010influential citation
• Hematogones: a review and update

  2009cites this paper
• B-acute leukemic lymphoblasts versus hematogones: the wolf in sheep's clothing/

  2009cites this paper
• Characterization of immunophenotypic aberrancies in 200 cases of B acute lymphoblastic leukemia.

  2009cites this paper
• The use of receiver operating characteristic analysis for detection of minimal residual disease using five‐color multiparameter flow cytometry in acute myeloid leukemia identifies patients with high risk of relapse

  2009cites this paper
• Significant CD5 expression on normal stage 3 hematogones and mature B Lymphocytes in bone marrow.

  2009cites this paper
• Aberrant underexpression of CD81 in precursor B-cell acute lymphoblastic leukemia: utility in detection of minimal residual disease by flow cytometry.

  2009cites this paper
• Acute lymphoblastic leukemia.

  2009influential citation
• The pattern of cytoplasmic IgM expression in the context of the three currently recognised maturational stages of hematogones

  2009cites this paper
• Incidence, sensitivity, and specificity of leukemia-associated phenotypes in acute myeloid leukemia using specific five-color multiparameter flow cytometry.

  2008cites this paper
• Stability of Leukemia-Associated Immunophenotypes in Precursor B-Lymphoblastic Leukemia/Lymphoma: A Single Institution ExperienceChen W, Karandikar NJ, McKenna RW, et al (Univ of Texas, Dallas) Am J Clin Pathol 127:39–46, 2007§

  2008cites this paper
• Immunophénotypage des hémopathies malignes par cytométrie de flux

  2008cites this paper
• Multiparameter flow cytometric analysis reveals low percentage of bone marrow hematogones in myelodysplastic syndromes.

  2008cites this paper
• Acute lymphoblastic leukemia: diagnosis and detection of minimal residual disease following therapy.

  2007cites this paper
• Utilidad del inmunofenotipo en el diagnóstico y el seguimiento de la leucemia linfoblástica aguda del adulto

  2007cites this paper